Arnar J Jonsson1, Sigrun H Lund1, Bjørn O Eriksen2, Runolfur Palsson1, Olafur S Indridason3. 1. University of Iceland, Reykjavik, Iceland. 2. Metabolic and Renal Research Group, UiT The Arctic University of Norway, Tromsö, Norway. 3. Internal Medicine Services, Landspitali-The National University Hospital of Iceland, Reykjavik, Iceland.
Abstract
Background: Information on the incidence of chronic kidney disease (CKD) in the general population is scarce. This study examined the incidence and risk factors of CKD stages 1-5 in Iceland, based on multiple markers of kidney damage. Methods: All serum creatinine (SCr) values, urine protein measurements and diagnosis codes for kidney diseases and comorbid conditions for people aged ≥18 years were obtained from electronic medical records of all healthcare institutions in Iceland in 2008-2016. CKD was defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria as evidence for kidney damage and/or estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2 for >3 months. Alternatively, CKD was defined using age-adapted eGFR thresholds. Mean annual age-standardized incidence of CKD was calculated for persons without CKD at study entry. Risk factor assessment was based on International Classification of Diseases diagnosis codes. Incidence was reported per 100 000 population. Results: We retrieved 1 820 990 SCr values for 206 727 persons. Median age was 45 years (range, 18-106) and 47% were men. Mean annual age-standardized incidence of CKD per 100 000 was 649 in men and 694 in women, and 480 in men and 522 in women using age-adapted eGFR thresholds. The incidence reached over 3000 in men and women aged >75 years. Traditional CKD risk factors, such as acute kidney injury, diabetes, hypertension and cardiovascular disease, as well as less well characterized risk factors, including chronic lung disease, malignancy and major psychiatric illness were associated with increased risk of CKD, and the same was true for obesity and sleep apnoea in women. Conclusion: The annual incidence of CKD, with strict adherence to the KDIGO criteria, was <0.7% but markedly lower using age-adapted eGFR thresholds. Apart from acute kidney injury, the observed risk factors comprised chronic and potentially modifiable disorders.
Background: Information on the incidence of chronic kidney disease (CKD) in the general population is scarce. This study examined the incidence and risk factors of CKD stages 1-5 in Iceland, based on multiple markers of kidney damage. Methods: All serum creatinine (SCr) values, urine protein measurements and diagnosis codes for kidney diseases and comorbid conditions for people aged ≥18 years were obtained from electronic medical records of all healthcare institutions in Iceland in 2008-2016. CKD was defined according to the Kidney Disease: Improving Global Outcomes (KDIGO) criteria as evidence for kidney damage and/or estimated glomerular filtration rate (eGFR) <60 mL/min/1.73 m2 for >3 months. Alternatively, CKD was defined using age-adapted eGFR thresholds. Mean annual age-standardized incidence of CKD was calculated for persons without CKD at study entry. Risk factor assessment was based on International Classification of Diseases diagnosis codes. Incidence was reported per 100 000 population. Results: We retrieved 1 820 990 SCr values for 206 727 persons. Median age was 45 years (range, 18-106) and 47% were men. Mean annual age-standardized incidence of CKD per 100 000 was 649 in men and 694 in women, and 480 in men and 522 in women using age-adapted eGFR thresholds. The incidence reached over 3000 in men and women aged >75 years. Traditional CKD risk factors, such as acute kidney injury, diabetes, hypertension and cardiovascular disease, as well as less well characterized risk factors, including chronic lung disease, malignancy and major psychiatric illness were associated with increased risk of CKD, and the same was true for obesity and sleep apnoea in women. Conclusion: The annual incidence of CKD, with strict adherence to the KDIGO criteria, was <0.7% but markedly lower using age-adapted eGFR thresholds. Apart from acute kidney injury, the observed risk factors comprised chronic and potentially modifiable disorders.
Authors: K Yamagata; K Ishida; T Sairenchi; H Takahashi; S Ohba; T Shiigai; M Narita; A Koyama Journal: Kidney Int Date: 2006-11-22 Impact factor: 10.612
Authors: Lori D Bash; Josef Coresh; Anna Köttgen; Rulan S Parekh; Tibor Fulop; Yaping Wang; Brad C Astor Journal: Am J Epidemiol Date: 2009-06-17 Impact factor: 4.897
Authors: Robert G Nelson; Morgan E Grams; Shoshana H Ballew; Yingying Sang; Fereidoun Azizi; Steven J Chadban; Layal Chaker; Stephan C Dunning; Caroline Fox; Yoshihisa Hirakawa; Kunitoshi Iseki; Joachim Ix; Tazeen H Jafar; Anna Köttgen; David M J Naimark; Takayoshi Ohkubo; Gordon J Prescott; Casey M Rebholz; Charumathi Sabanayagam; Toshimi Sairenchi; Ben Schöttker; Yugo Shibagaki; Marcello Tonelli; Luxia Zhang; Ron T Gansevoort; Kunihiro Matsushita; Mark Woodward; Josef Coresh; Varda Shalev Journal: JAMA Date: 2019-12-03 Impact factor: 56.272
Authors: William E Haley; Felicity T Enders; Lisa E Vaughan; Ramila A Mehta; Maxton E Thoman; Terri J Vrtiska; Amy E Krambeck; John C Lieske; Andrew D Rule Journal: Mayo Clin Proc Date: 2016-10-21 Impact factor: 7.616
Authors: Masao Iwagami; Kathryn E Mansfield; Joseph F Hayes; Kate Walters; David Pj Osborn; Liam Smeeth; Dorothea Nitsch; Laurie A Tomlinson Journal: Clin Epidemiol Date: 2018-04-16 Impact factor: 4.790